Overview
LUNG market data
Price History
LUNG price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.33 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.31 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -55.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.13 – $2.89 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $97.9M · P/B 1.68 · P/S 1.12.
Company News
Pulmonx shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Jul 29, 2026, 8:47 PM
Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.832M EstBenzinga · Jul 29, 2026, 8:15 PM
8-K filing — Pulmonx Corp (LUNG)SEC EDGAR · Jul 29, 2026, 8:07 PM
Pulmonx Q2 EPS $(0.24) Beats $(0.28) Estimate, Sales $22.756M Beat $22.400M EstimateBenzinga · Jul 29, 2026, 8:05 PM